Any thoughts on this company. Seemes to have good phase11 trail results in both their anti obesity drug and Irratable bowel syndrome drugs.
Much appreciated
Makes a change for a bio tech com to do well.
Thanks in advance

I also want ot know what happen the share keep droping in whole morning.

Again it seems the market in general has dropped but now from 14 points down it seems to be climbing again. I think as has been mentioned above, profit taking and safe guarding their margins. No doubt it will climb again. This share did the same thing two weeks ago.

Am I misiing something here or is there something of a over sell. The only news I can find is positive. If anyone can please enlighten. I have bought more based on myor. Help

can anyone let me know what really happen right now? the share seemed keep dropping and dropping today and yesterday.

It quadrupled in 6 weeks, what do you expect? The news dried up, and it probably won't go up until the next news is out (which may not be until next year), or until bid rumours start up again.

IN the meantime, entirely possible that it might just drift down a few pence a day. 150p quite likely, IMHO, and 120p not out of the question. Personally, I'll be delighted to see 120p - because I have a great belief in the long-term strength of the company.

i think they seemed have something wrong inside, they keep dropping.....

I agree stick with it, this has 200p written all over it short-term, just imagine how much the large pharmas would like to get their hands on alizyme's patents, I bet their md is sic to his back teeth of offers for the company or licenses deals. Lets face it the pipeline of products is in a very healthy state, more so than celltech and how much are they valued at, dyor but this will fly higher than 200p longterm perhaps even 400p.

I agree stick with it, this has 200p written all over it short-term, just imagine how much the large pharmas would like to get their hands on alizyme's patents, I bet their md is sic to his back teeth of offers for the company or licenses deals. Lets face it the pipeline of products is in a very healthy state, more so than celltech and how much are they valued at, dyor but this will fly higher than 200p longterm perhaps even 400p.

I agree stick with it, this has 200p written all over it short-term, just imagine how much the large pharmas would like to get their hands on alizyme's patents, I bet their md is sic to his back teeth of offers for the company or licenses deals. Lets face it the pipeline of products is in a very healthy state, more so than celltech and how much are they valued at, dyor but this will fly higher than 200p longterm perhaps even 400p.

Glad to see it on the way back. Despite all the research, I must admit I did start to get quite a panic on :-)
I bought at 126, 160 and 192. And up to three days ago I was feeling decidely queasey about this stock lol. Still holding as nothing seems to suggest it is other then a good bet medium to long term.

It rise again today. so keep waiting 2 pound target not far away.....

A favourite of mine, next year should be VERY interesting and as zzaxx99 says, a bid might come anytime. I bought at 54p 75p 154p and 159.48p....but angling for more. Never know, might be able to call it a day on the internet BB's. That would please the wife no end! :))

Good night from me

What happen it rise 7%....

Rise on bid rumours (see Guardian, Indie etc) - supposedly at 2.20 but denied by the company! 2.20 is way too cheap so dont expect much to come out of this - but a bid war would be fun (and quite bloody!!)

stiil looking good. touching 2 pound soon.

What's wrong today???

Just the market in general doing bad. However biotecs seem to be getting the worst of it.

do anyone know when will AZm have news next time, beucase it seemed dind`t hear anything for long

Other then progress reports, phase 111 results will not be available until middle of next year. However several pharma's will be keeping an eye on them with a view to sealing contracts before then if the trials are going in the right direction. Their irritable bowl syndrom drug will give good leverage in future contracts for their anti obesity drug.

drop a bit today